Publications and outputs Biological Security Research Centre

2022

1. Si-xian Wu, Xiao-liang Li, Li-jun Shang, Lv-ying Wu, Tong-tong Li, Pei-yv Li, Zhi-liang Ji, Jian-wen Hou, Ming-zhu Yin, Wen-ming Xu. A novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice. 2022, Acta Biochimica et Biophysica Sinica, in press
2. Junhong Zhao, You Zhou, Jing Zhang, Kejin Zhang, Lijun Shang*, Junlin Li*. Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae. 2022, Experimental Eye Research. * co-corresponding authors, 2022, in press
3. Lijun Shang, Michael Mprah, Indrajitrakuraj Ravi, Malcolm Dando. Key Issues in the Implementation of the Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists: A Survey of Biosecurity Projects. Biosafety and Health. 2022, in press
4. Nariyoshi Shinomiya, Jusaku Minari, Go Yoshizawa, Malcolm Dando, Lijun Shang (2022), Reconsidering the Need for Gain-of-Function Research on Enhanced Potential Pandemic Pathogens in the Post-COVID-19 Era. Front. Bioeng. Biotechnol. 10:966586. doi: 10.3389/fbioe.2022.966586
5. Gelin Huang, Xueguang Zhang, Guanping Yao, Lin Huang, Sixian Wu, Xiaoliang Li, Juncen Guo, Yuting Wen, Yan Wang, Lijun Shang, Na Li, Wenming Xu. A loss-of-function variant in SSFA2 causes male infertility with globozoospermia and failed oocyte activation. 2022, Reproductive Biology and Endocrinology, (2022) 20:103. https://doi.org/10.1186/s12958-022-00976-5
6. Yang Xue, Lijun Shang. (2022) Towards Better Governance on Biosafety and Biosecurity: China’s Advances and Perspectives in Medical Biotechnology Legislation. 2022, Front. Bioeng. Biotechnol. 10:939295. doi: 10.3389/fbioe.2022.939295
7. Huaiyu Tong, Chongye Guo, Liang Liang, Hua Mi, Meng Li, Yiheng Yin, Lijun Shang*, Shuangli Mi*, Xinguang Yu*.  Implication of a de novo Variant in ciliary rootlet coiled coil (CROCC) with assimilation of atlas (AOA). Genetics & Applications.  2022, 6(1): DOI: 10.31383/ga.vol6iss1pp11-26 *co-corresponding authors
8. Yang Xue, Lijun Shang. Governance of Heritable Human Gene Editing World-Wide and Beyond. International Journal of Environmental Research and Public Health. 2022, 19(11), 6739
9. Tatyana Novossiolova, Simon Whitby, Malcolm Dando, Lijun Shang. Strengthening Biological Security after COVID-19: Using cartoons for engaging life science stakeholders with the Biological and Toxin Weapons Convention (BTWC). Journal of Biosafety and Biosecurity. 2022, 4:68-74
10. Brett Edwards, Tatyana Novossiolova, Michael Crowley, Simon Whitby, Malcolm Reginald Dando and Lijun Shang. Meeting the Challenges of Chemical and Biological Weapons: Strengthening the Chemical and Biological Disarmament and Non-Proliferation Regimes. Frontiers in Political Science. 2022, 4:805426
11. Yang Xue, Lijun Shang, Jinwen Zang. Building a Multiple-level System of Ethical Code for Biological Scientists under the Biological and Toxin Weapons Convention (BTWC) of the United Nations with Effective Implementation. Journal of Biosafety and Biosecurity. 2021, 3:108-119

2021

1. Caijuan Dong, Aiqun Ma, Lijun Shang. Animal models used in the research of nanoparticles for cardiovascular diseases. Journal of Nanoparticle Research. 2021, 23, 172.
2. Zhuoyue Chen, Zhen Zhang, Zhaoyue Wang, Jiawei Wu, Yihang Wang, He Si, Xin Xie, Lijun Shang*, Daidi Fan*, Fulin Chen*. Fabricating a novel HLC-hBMP2 fusion protein for the treatment of bone defects. Journal of Controlled Release. 2021,329: 270-285. *co-corresponding authors
3. Malcolm Dando, Tatyana Novossiolova, Michael Crowley and Lijun Shang (2021). Towards an Aspirational (Ethical) Code under the Biological and Toxin Weapons Convention: Engaging the Life Science Community. CBW Magazine: Journal on Chemical and Biological Weapons. 2021; 14, 2: 4-23